NCT02714296

Brief Summary

This study is an open, prospective, comparative diagnostic studies aimed at improving the colonoscopy results, by optimizing the way of preparation for endoscopy

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P50-P75 for phase_4

Timeline
Completed

Started Mar 2016

Shorter than P25 for phase_4

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2016

Completed
15 days until next milestone

First Submitted

Initial submission to the registry

March 16, 2016

Completed
5 days until next milestone

First Posted

Study publicly available on registry

March 21, 2016

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2016

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2016

Completed
Last Updated

April 13, 2017

Status Verified

April 1, 2017

Enrollment Period

6 months

First QC Date

March 16, 2016

Last Update Submit

April 11, 2017

Conditions

Keywords

colon preparation for endoscopyenteral feedingsip feedingnutridrinknutridrink compact protein

Outcome Measures

Primary Outcomes (1)

  • the degree of preparation in the colonoscopy (Chicago or Boston scale).

    before colonoscopy

Secondary Outcomes (1)

  • tolerability

    before colonoscopy

Study Arms (3)

Group Nutridrink 200ml

ACTIVE COMPARATOR

50 patients: two days before the investigation is assigned to a diet with the use of specialized clinical nutrition Nutridrink 200 ml 6 bottles per day as a sole source of nutrition. On the day of the colonoscopy, as breakfast, allowed Nutridrink 1-2 bottles

Drug: Nutridrink 200 ml

Group Nutridrink compact protein

ACTIVE COMPARATOR

two days before the study is assigned diet with the addition of specialized clinical nutrition Nutridrinc compact protein 125 ml 2 bottles per day. On the day of the colonoscopy, as breakfast, allowed Nutridrink compact protein 1-2 bottles

Dietary Supplement: Nutridrink compact protein

Group control

NO INTERVENTION

only diet without receiving specialized nutrition

Interventions

Nutridrink 200 ml 6 bottles per day as a sole source of nutrition. On the day of the colonoscopy, as breakfast, allowed Nutridrink 1-2 bottles

Group Nutridrink 200ml
Nutridrink compact proteinDIETARY_SUPPLEMENT

2 bottles per day. On the day of the colonoscopy, as breakfast, allowed Nutridrink compact protein 1-2 bottles

Group Nutridrink compact protein

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients older than 18 years with the recommendation to conduct a diagnostic colonoscopy
  • Absence of contraindications to the use of specialized clinical nutrition products

You may not qualify if:

  • Conditions which are contraindicated for colonoscopy:
  • The acute phase of cerebrovascular accident
  • Acute myocardial infarction
  • severe cardiovascular, pulmonary insufficiency and mixed
  • Violations of the cardiac rhythm (paroxysmal bradyarrhythmia, atrial fibrillation with atrial fibrillation or paroxysmal atrial fibrillation, severe transverse heart block)
  • Severe clinical forms (fulminant) inflammatory diseases of the colon (ulcerative colitis, Crohn's disease, ischemic colitis, radiation colitis, diverticulitis)
  • Aortic aneurysm or heart
  • Acute inflammatory infiltrates abdominal cavity (including diverticulitis)
  • Suspicion of abscess of the abdominal cavity
  • Peritonitis
  • Hepatosplenomegaly
  • Tense ascites
  • hydrothorax, hydropericardium
  • Severe blood coagulation
  • Hemorrhagic vasculitis
  • +3 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

ГНЦ колопроктологии

Moscow, 123103, Russia

Location

Study Officials

  • Elena Volkova

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 16, 2016

First Posted

March 21, 2016

Study Start

March 1, 2016

Primary Completion

September 1, 2016

Study Completion

November 1, 2016

Last Updated

April 13, 2017

Record last verified: 2017-04

Locations